A&G Pharmaceutical, INC.
UEI SN6SWFABJXL1 · MD · SAM.gov record ↗
$20K
FY2025 obligations
6
Contract awards
Jun 17, 2020
First action
May 4, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$20K
Obligations by NAICS
Monthly obligations
Feb 25
Mar 25
Jun 25
Sep 25
Jan 26
Apr 26
May 26
Contracts ending within 18 months (recompete watch)
- 75N95C25P00114 ↗$14K
TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT.
- Ends
- Sep 22, 2026
- Started
- Sep 23, 2025
- Agency
- National Institutes Of Health
- NAICS
- 325998
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N95C25P00114 ↗ | TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT. | National Institutes Of Health | 325998 | $14K | Sep 23, 2025 | Sep 22, 2026 |
Largest awards
- 75N93025P00729 ↗$17K
MONOCLONAL ANTIBODY AGAINST MARCH1 PREPARATION MAB-P3-00-001, 002, 003, 005 AND MAB-P3-HC-001 (AMBIS #2254762)
- Ends
- Jul 30, 2025
- Started
- Mar 24, 2025
- Agency
- National Institutes Of Health
- NAICS
- 325414
- 75N95C25P00114 ↗$14K
TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT.
- Ends
- Sep 22, 2026
- Started
- Sep 23, 2025
- Agency
- National Institutes Of Health
- NAICS
- 325998
O/M ITEMS ONLY: BIOLOGICAL MATERIALS, LABORATORY & TESTING SERVICES, ANIMAL TESTING SERVICES
- Ends
- —
- Started
- Jan 29, 2024
- Agency
- National Institutes Of Health
- NAICS
- 325412
- 75N95022F00001 ↗$-1K
FY26 UDO INITIATIVE POLYCLONAL RAT ANTIBODY AND MONOCLONAL RAT ANTIBODIES AGAINST GLYCOL-CHITOSAN NANOPARTICLES
- Ends
- Mar 30, 2025
- Started
- Jun 29, 2022
- Agency
- National Institutes Of Health
- NAICS
- 541715
- 75N93024P01059 ↗$-3K
FY26 UDO INITIATIVE PRECISION ANTIBODY (AMBIS #2229539) LAB TESTING, FUSION, CLONING
- Ends
- Nov 29, 2024
- Started
- Aug 26, 2024
- Agency
- National Institutes Of Health
- NAICS
- 541380
- 75N91020P00499 ↗$-6K
TO DE-OBLIGATE FUNDS FROM FY2020 EXPIRING LINES FOLLOWING NIH OALM COMMUNICATION 25-06 (20241105).
- Ends
- Jun 18, 2020
- Started
- Jun 17, 2020
- Agency
- National Institutes Of Health
- NAICS
- 541714
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75N93025P00729 ↗ | MONOCLONAL ANTIBODY AGAINST MARCH1 PREPARATION MAB-P3-00-001, 002, 003, 005 AND MAB-P3-HC-001 (AMBIS #2254762) | National Institutes Of Health | 325414 | $17K | Mar 24, 2025 | Jul 30, 2025 |
| 75N95C25P00114 ↗ | TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT. | National Institutes Of Health | 325998 | $14K | Sep 23, 2025 | Sep 22, 2026 |
| 75N98024A00057 ↗ | O/M ITEMS ONLY: BIOLOGICAL MATERIALS, LABORATORY & TESTING SERVICES, ANIMAL TESTING SERVICES | National Institutes Of Health | 325412 | $0 | Jan 29, 2024 | — |
| 75N95022F00001 ↗ | FY26 UDO INITIATIVE POLYCLONAL RAT ANTIBODY AND MONOCLONAL RAT ANTIBODIES AGAINST GLYCOL-CHITOSAN NANOPARTICLES | National Institutes Of Health | 541715 | $-1K | Jun 29, 2022 | Mar 30, 2025 |
| 75N93024P01059 ↗ | FY26 UDO INITIATIVE PRECISION ANTIBODY (AMBIS #2229539) LAB TESTING, FUSION, CLONING | National Institutes Of Health | 541380 | $-3K | Aug 26, 2024 | Nov 29, 2024 |
| 75N91020P00499 ↗ | TO DE-OBLIGATE FUNDS FROM FY2020 EXPIRING LINES FOLLOWING NIH OALM COMMUNICATION 25-06 (20241105). | National Institutes Of Health | 541714 | $-6K | Jun 17, 2020 | Jun 18, 2020 |